Abbott's Trading Volume Drops 37% Ranking 101st Despite 051% Share Gain

On June 27, 2025, Abbott's trading volume reached $792 million, a 37.48% decrease from the previous day, ranking 101st in the day's stock market activity. Abbott (ABT) shares rose by 0.51%.

Abbott Laboratories is scheduled to release its second-quarter 2025 financial results on Thursday, July 17, before the market opens. The company will host a conference call on the same day to discuss the earnings report.

Investors are closely monitoring Abbott's upcoming earnings disclosure, with the company's projected EPS for the quarter at $1.25, indicating a 9.65% increase year-over-year. The Zacks Consensus Estimate for revenue is $11.05 billion, up 6.45% from the previous year. For the full year, earnings are forecasted at $5.16 per share and revenue at $44.68 billion, reflecting increases of 10.49% and 6.52% respectively.

Recent changes to analyst estimates for Abbott suggest a dynamic outlook for the company. Positive estimate revisions often correlate with near-term stock price movements, and Abbott currently holds a Zacks Rank of #3 (Hold).

In terms of valuation, Abbott is trading at a Forward P/E ratio of 26.65, higher than its industry average of 18.81. The company's PEG ratio stands at 2.61, compared to the industry average of 2.28. The Medical - Products industry, part of the broader Medical sector, is currently ranked 162 out of 250+ industries, placing it in the bottom 35%.